View and valuation:
BDL is inline with capability building to carter future growth. We expect order execution to pick up from FY25 onwards led by various order execution such as in the near term, the company expects execution of program such as Astra Mk-1, SAAW, ULPGM, Drone fired Bombs, SPIKE-ER, 70MM LGR orders by FY25 and QRSAM, NAG ATGM, Advanced Torpedo, MIGM, GRAD Rockets by FY26. Post that the company expects Akash-NG, VLRSAM, MPATGM, Heavy weight Torpedo, AMOGHA-III ATGM, MISTRAL, ...
Reduce Bharat Dynamics Ltd For Target Rs.1501 By Choice Broking Ltd
* India Formulations: The formulations segment generated revenue of INR 13,758 mn, reflecting a 12% YoY growth, primarily driven by strong volume growth in pillar brands and innovative products, contributing 22.8% to total sales. The company launched 10 new products, including 3 first-in-India launches, and outpaced the IPM in key therapies such as Cardiology, Gynecology, Dermatology, Respiratory, Antiinfectives, and super-specialty areas like Oncology and Nephrology. The company maintained i...
Buy Zydus Lifesciences Ltd For Target Rs. 1,319 By Choice Broking Ltd
* Commencement of 3 spoke models: For the first time, Rainbow has launched threespoke hospitals with a total of 280 beds across Hyderabad, Bangalore, and Chennai, bringing the total capacity to 2,000 beds. Additionally, a new block has been added to the existing hospital in Hyderabad, and an outpatient clinic has been opened in Hennur, Bengaluru.
* An uptick in Inpatient and Outpatient volume: During the quarter, the company experienced solid growth in IPD volumes, which increased by 10.2%...
Buy Rainbow Children’s Medicare Ltd For Target Rs. 1,345 By Choice Broking Ltd
Grasim Industries Ltd. reported standalone revenues of INR68,939mn for Q1FY25, reflecting a 1.9% increase QoQ and a 10.5% increase YoY, driven by strong performance across its diversified business portfolio. The Cellulosic Staple Fibre, Building Materials, and Financial Services segments particularly excelled. However, EBITDA for the quarter declined to INR3,251mn, down 38.3% QoQ and 51.7% YoY, primarily due to investments in the Paints business. The EBITDA margin for the quarter dropped to 4...
Buy Grasim Industries Ltd For Target Rs.2,780 By Choice Broking Ltd
In Q1FY25, Medanta's performance was below expectations. Revenue reached INR 8,611 mn, showing a growth of 11.4% YoY and 6.5% QoQ. The ARPOB for matured hospitals grew by 3.2% YoY to INR 67,160, while for developing hospitals, it declined by 1.7% QoQ to INR 58,205. Occupancy for developed hospitals came in at 63%, compared to 60% last year, whereas for developing hospitals, it was 52% versus 54% last year. Consolidated EBITDA increased by 4.7% YoY and 3.9% QoQ to INR 1,863 mn. However, th...
Buy Global Health Ltd For Target Rs.1,246 By Choice Broking Ltd
